3C
OMCL icon

361 Capital’s Omnicell OMCL Stock Holding History

361 Capital’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,236
Closed -$802K – 371
2020
Q1 		$802K Sell
12,236
-2,903
-19% -$231K 0.36% 103
2019
Q4 		$1.24M Sell
15,139
-16,672
-52% -$1.28M 0.34% 153
2019
Q3 		$2.3M Sell
31,811
-1,423
-4% -$104K 0.43% 126
2019
Q2 		$2.86M Buy
+33,234
New +$2.7M 0.51% 49

Other funds holding OMCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

361 Capital's OMCL Position: Q2 2020 in Review

361 Capital sold out of Omnicell (OMCL) in Q2 2020, closing a stake of 12,236 shares — an estimated $802K sold.

361 Capital first reported a position in OMCL in Q2 2019 and held it in 4 quarters. The position peaked at $2.86M in Q2 2019. 295 funds tracked by Wall St. Rank hold OMCL as of Q2 2020.

  • 361 Capital reported no remaining Omnicell position as of Q2 2020 after selling out during the quarter.
  • 361 Capital sold 12,236 Omnicell shares in Q2 2020, an estimated $802K.
  • 361 Capital first reported a position in Omnicell in Q2 2019 and held it in 4 quarters.
  • 361 Capital's Omnicell position peaked at $2.86M in Q2 2019.
  • 295 funds tracked by Wall St. Rank held Omnicell as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.